CWGL · Crimson Wine Group, Ltd
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Direct to Consumer gross margin percentage | 63% | Three Months Ended June 30, 2026 filing | -6.0% |
|
|
|||
| Total gross margin percentage | 42% | Three Months Ended June 30, 2026 filing | -8.7% |
|
|
|||
| Wholesale gross margin percentage | 36% | Three Months Ended June 30, 2026 filing | -5.3% |
|
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Beverages - Wineries & Distilleries — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CWGL
this stock
Crimson Wine Group, Ltd
|
$88.73M | -12.4% | -10.8% | 107.8 | 0.0% |
|
DEO
Diageo PLC
|
$47.31B | -1.8% | — | — | 0.6% |
|
BF-B
Brown Forman Corp
|
$12.06B | +0.4% | -1.2% | 17.0 | 7.1% |
|
APHD
Verde Bio Holdings, Inc.
|
$2.59B | +85.2% | -100.0% | — | 0.0% |
|
SNDL
SNDL Inc.
|
$344.57M | -25.3% | — | — | 0.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CWGL | -4.7% | +0.7% | -2.9% | +1.4% | -12.5% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -4.5% | +1.2% | -15.1% | +0.5% | -25.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.